“Dietary control of the Resolution Response™ may have a far greater impact on the future of medicine than genetic engineering”
– Dr. Barry Sears
Join our community and gain exclusive access to Dr. Sears' latest publications, resources, tools, and more.
Dr. Sears' Blog
Is There Something Fishy About Vascepa®?
Recently the FDA has allowed an expanded drug use for Vascepa® to reduce cardiovascular events in subjects with established heart disease and triglyceride levels greater than 150 mg/dL. Vascepa is a drug composed of highly-refined EPA ethyl esters consisting of 96 percent EPA. Vascepa is not a new drug. The same compound (sold as Epadel®) has been used in Japan for more than 30 years for treating elevated triglyceride levels since 1988, but its patent expired (1).
What Leading Medical Researchers Have to Say
“The Resolution Zone is a must read. Dr. Sears’ vision is clearly presented building on fundamental new discoveries from experimental medicine. I highly recommend this book and hope you’ll embrace its very valuable messages.”
Professor Charles N. Serhan, PhD, DSc.,
Endowed Professor Harvard Medical School, Distinguished Scientist and Director, Center for Experimental Therapeutics at Brigham and Women’s Hospital